Stoops, don't twist my words around. As I've always made clear I'm quite happy to sit on CUX as a spec and see what develops but toilet rolls of guesswork calculation don't alter the intended use of the original product anymore than they enhance CUX. Quite frankly there is no where near enough info from CUX to make an informed decision ATM, particularly in relation to Lynas. IMO there is a very dark 6 months or so ahead for wannabe ROW RE stocks and CUX will do well just to be one of the survivors.
CUX Price at posting:
3.7¢ Sentiment: Hold Disclosure: Held
